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important limitations of conventional
devices but only provide single-chamber
pacing capability.
 The presented concept involves 2 leadless
pacemakers that communicate wirelessly
with each other and thus enable
synchronized leadless dual-chamber pacing.
 A novel technology is presented for
pacemaker communication, using the
myocardium and blood as the
transmission medium. Optimal
communication parameters were assessed
in vivo and in vitro, and various features
having an inﬂuence on signal transmission
have been identiﬁed.
 A leadless dual-chamber pacemaker
prototype was developed and successfully
tested in vivo.
 The presented technique has shown to be
a promising and energy-efﬁcient wireless
communication method for leadless dual-
chamber pacemakers.All authors have reported that they
are regulations of the authors’ in-
opriate. For more information, visit
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815SUMMARY
AB BAND ACRONYM S
AV = atrioventricular
ECG = electrocardiogram
LV = left ventricle
PM = pacemaker
RA = right atrium
RV = right ventricleContemporary leadless pacemakers only feature single-chamber pacing capability. This study presents a pro-
totype of a leadless dual-chamber pacemaker. Highly energy-efﬁcient intrabody communication was imple-
mented for wireless pacemaker synchronization. Optimal communication parameters were obtained by in vivo
and ex vivo measurements in the heart and blood. The prototype successfully performed dual-chamber pacing
in vivo. The presented wireless communication method may in the future also enable leadless cardiac
resynchronization therapy. (J Am Coll Cardiol Basic Trans Science 2018;3:813–23) © 2018 The Authors.
Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).T oday, >1 million cardiac pacemakers (PMs)are implanted per year (1), the majority ofwhich are conventional PMs. These devices
consist of a subcutaneously implanted generator and
pacing leads. However, conventional PM systems suf-
fer from limitations: w10% of PM patients experience
complications, which are mostly related to the pacing
leads or involve pocket-related complications (2,3).
To overcome these limitations, leadless single-
chamber PMs have been introduced. These devices
are implanted inside the right ventricle using dedi-
cated delivery catheters. In addition to offering a
cosmetic beneﬁt, the leadless design and the lack of a
surgically created subcutaneous pocket eliminate ma-
jor drawbacks. To date, 2 leadless PMs are commer-
cially available: Micra (Medtronic, Minneapolis,
Minnesota) and Nanostim (St. Jude Medical, St. Paul,
Minnesota) (4–8). However, these devices have the
signiﬁcant limitation of performing single-chamber
ventricular pacing only. Therefore, present leadless
PMs are not well suited for the majority of patients in
whom a dual-chamber system or cardiac resynchroni-
zation therapy is preferred due to medical reasons (9).
Communication between different pacing sites is also
key to reducing right ventricular pacing. Hence,
dual-chamber pacing systems that proﬁt from the ad-
vantages of leadless PMs are highly desirable.
The concept proposed in the present study
involves multiple implanted leadless PMs that jointly
act as a leadless dual-chamber PM system (Figure 1).
To preserve synchrony, these devices must commu-
nicate wirelessly with each other. A typical commu-
nication scenario in a leadless dual-chamber PM
system could work as follows: the atrial PM stimu-
lates the right atrium (RA) and immediately sends a
synchronization message to the ventricular PM that
comprises information such as the atrioventricular
pacing delay. This message is received almost
instantly by the ventricular PM, which reacts
accordingly within the same heart cycle. Therefore,the connection has to be established in a very short
time although the amount of transferred data is very
small. Furthermore, leadless PMs consume only 5 to
10 mW of power (according to device manufacturer’s
reference manuals), which is important due to the
highly restricted battery volume. Therefore, the
communication must be very energy efﬁcient and
should not signiﬁcantly reduce the lifetime of a PM.
Inside the body, these requirements can typically not
be met with wireless data communications based on
radiofrequency telemetry and inductive coupling (as
used by conventional cardiac implantable devices)
(10,11). In contrast, galvanic coupled intrabody
communication (12) is a promising approach for
wireless data transfer between implanted devices.
It uses the tissue as a transmission medium for
electrical signals: the data from one device are
modulated and applied as a small alternating current
signal to the tissue via electrodes. This current
will propagate in the tissue and can be registered
almost simultaneously by another device.
Galvanic coupled intrabody communication has
mainly been investigated as a wireless communica-
tion method for on-body biomedical sensor networks
(10,12). To characterize the human body as a trans-
mission medium for electrical current, tissue prop-
erties and geometrical alignment inﬂuences have
been investigated. However, most studies focus on
transmission between body extremities using surface
electrodes (13–15). For the proposed communication
between leadless PMs, the dominant transmission
medium is the myocardium/blood, and the commu-
nication electrodes are preferably the PM electrodes.
In the present study, the heart’s electrical signal
transmission characteristics were assessed to develop
a prototype of a leadless dual-chamber PM using
intrabody communication for device synchroniza-
tion. The PM underwent in vivo testing to investigate
the method’s acute safety and ability to allow multi-
site pacing.
FIGURE 1 Leadless Dual-Chamber Pacemaker
Leadless pacemakers are implanted in the right atrium and the
right ventricle. To synchronize, the devices communicate
wirelessly with each other.
FIGURE 2 Schematic Setup of Ex Vivo and In Vivo Measurements and
Representation of Introduced Parameters
electrode
pair
heart tissue
Two electrode pairs penetrate the myocardium with deﬁned geometrical
relations: electrode distance (de), device distance (dd), and penetration
depth (dp). The signal attenuation in the tissue is deﬁned by the relation of
the voltages Vtransmitter and Vreceiver.
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816METHODS
IMPEDANCE AND TRANSFER FUNCTION MEASUREMENTS.
To build the wireless dual-chamber PM, we ﬁrst
investigated the key characteristics for intrabody
communication inside the heart. The impedance be-
tween the communication electrodes Ze is a ﬁrst key
parameter to be characterized. It is mainly deﬁned by
the surrounding tissue, the electrode distance (de),
and the electrode penetration depth (dp) (Figure 2).
Ultimately, the impedance affects the transmitted
power during communication. The second key
parameter is the transfer function ðHðf ÞÞ, which de-
scribes the frequency-dependent attenuation of the
electrical signal in the tissue. It is a relation between
the voltage (Vtransmitter), which is applied by the
transmitting electrode pair, and the voltage Vreceiver,
measured by the receiving electrode pair at a
different location:
Hðf Þ ¼ 20$log10

Vreceiver
Vtransmitter

(Equation 1)
The speciﬁc range of impedances and the transfer
functions of myocardial tissue were determined with
measurements on porcine hearts. To obtain realistic
results, measurements were performed either ex vivo
on beating hearts (Langendorff technique [16]) or
in vivo on 60-kg domestic pigs. During the in vivo
measurement, the pig was under inhalation anes-
thesia and placed in a recumbent position. Before the
experiment, a bolus of 150 mg of amiodarone and
5,000 U of heparin were administered intravenously.
After performing a sternotomy, electrode ﬁxation
plates were sutured epicardially on the RA and the
right ventricle (RV). The electrodes were stuck into
the myocardium through the electrode ﬁxation plates
with different distances. Medical-grade stainless steel
needles with a maximal diameter of 0.55 mm (8140-8
Pc, Sutranox, Unimed S.A., Lausanne, Switzerland)
were used as electrodes.
Impedance was measured with an impedance
spectroscope (HF2IS in combination with HF2TA,
Zurich Instruments, Zurich, Switzerland). To acquire
the transfer function, a frequency sweep of a sinu-
soidal voltage (1 kHz to 1 MHz) was generated with a
signal generator (HF2IS, Zurich Instruments). The
peak voltage Vtransmitter was 100 mV and therefore
below the pacing threshold (4) to prevent unwanted
myocardial stimulation at low frequencies (w1 kHz).
The receiver voltage Vreceiver was ampliﬁed with
a custom-made, battery-powered measurement
ampliﬁer and measured with a battery-driven oscil-
loscope (RTH1004, Rohde & Schwarz, Munich, Ger-
many). The trials were approved by the Swiss
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817Federal Veterinary Ofﬁce and performed in compli-
ance with the Guide for the Care and Use of Labo-
ratory Animals.
Leadless PMs are mainly surrounded by blood.
Hence, the transfer function of porcine blood was
measured in addition to the heart measurements. A
container (100 ml volume) was ﬁlled with heparinized
(1 ml/l) blood, freshly harvested from the slaughter-
house. The needle electrodes were placed with elec-
trode distance de ¼ 10 mm and device distance
dd ¼ 25/50 mm. To achieve a different hematocrit, the
blood was diluted with Ringer’s solution. Hematocrit
levels were determined immediately before the
measurement by using the Hb 201 DM System
(HemoCue, Ängelholm, Sweden).
In addition, in vitro measurements were performed
on ventricular tissue samples (10 pieces, cut out
approximately 65  30  10 mm), which allowed for
the separate examination of the inﬂuence of elec-
trode distance de and penetration depth dp. The
needle electrodes were placed at a ﬁxed device dis-
tance of 20 mm. Subsequently, the transfer function
was measured at varying electrode distances (de ¼ 5/
10 mm) and penetration depths (dp ¼ 3/5 mm).
PROTOTYPES. The previously acquired impedance
and transfer function results were used as the basis to
develop prototypes of leadless PMs that feature dual-
chamber pacing. For this functionality, the
prototypes have to perform bidirectional communi-
cation; that is, every device has to be able to transmit
and receive data. Intrabody communication was
implemented using a suitable carrier frequency and
modulation method. The devices are battery-powered
by a USB power bank (PQI power 6000CV, PQI,
Shenzhen, China). For prototyping purposes, they
were not miniaturized, and an epicardial implanta-
tion site was intended.
The hardware concept of the prototypes is shown
as a block diagram in Figure 3. The prototypes
are built around a microcontroller development
board (NUCLEO-F103RB, STMicroelectronics, Geneva,
Switzerland). The settings, such as communication
and pacing parameters, can be conﬁgured via the user
interface. To send data, the signal generator gener-
ates a sinusoidal voltage with adjustable communi-
cation frequency fc. This signal is pulse position
modulated: the data are encoded as several pulses
with deﬁned time shifts. This technique allows the
transmission of several bits of data per pulse. In fact,
one pulse is a multiple of a period (nperiods) of the
communication frequency fc, which is the frequency
with lowest signal attenuation by the tissue. The time
required for sending one synchronization message isdeﬁned as tsync. To receive data, the voltage measured
at the electrodes is ampliﬁed with a differential
ampliﬁer, ﬁltered, and digitized with the micro-
controller’s analog-to-digital converter to obtain the
reconstructed data.
DUAL-CHAMBER PACING. To test the prototypes
in vivo, a domestic pig (60 kg) was prepared as
previously described. Electrode ﬁxation plates
were sutured on the RA, RV, and the left ventricle
(LV) (Figure 4), and the needle electrodes were
inserted. Before testing, the pacing impedance and
pacing threshold were measured with a CareLink
programmer (model 2090, Medtronic) via the inserted
electrodes. Subsequently, the prototypes were con-
nected to the electrodes and programmed to perform
asynchronous leadless dual-chamber pacing at a
higher rate than the pig’s intrinsic heart rate. A 3-lead
electrocardiogram (ECG) was recorded simulta-
neously (g.USBamp, g.tec medical engineering,
Schiedlberg, Austria).
The veriﬁcation of the communication reliability
was assessed by 3 measures. First, the ventricular PM
showed visual feedback upon reception of a syn-
chronization message. In addition, ventricular pacing
was veriﬁed by the altered ECG morphology
(widening and different conﬁguration of QRS com-
plex) and visible pacing spikes in the ECG (atrial and
ventricular).
ENERGY CONSUMPTION. To evaluate the suitability
of intrabody communication for leadless PMs, it is
essential to consider the energy required by the
communication. It can be divided into 2 parts. The
ﬁrst part is the electronic circuits’ energy consump-
tion (e.g., for signal ampliﬁcation and processing,
signal synthesis). In this proof-of-concept study, the
developed prototypes have not been optimized in
terms of energy efﬁciency. Therefore, emphasis is put
on the second type of energy consumption, which is
the transmitted energy. The transmitted energy is the
energy that is applied to the tissue for communication
(Esync is deﬁned as the dissipated energy for one
synchronization message). It is dependent on the
amplitude of the applied signal, the tissue impedance
Ze, and on communication-speciﬁc parameters:
Esync ¼
bI 2$
Ze
ﬃﬃﬃ
2
p $npulses $nperiods $
1
fc
(Equation 2)
RESULTS
IMPEDANCE AND TRANSFER FUNCTION MEASUREMENTS.
Measurements on 7 beating hearts (4 in vivo, 3 in a
FIGURE 3 Functional Block Diagram of the Pacemaker Prototypes
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To transmit, the data are pulse position modulated (PPM) and applied to the tissue via
electrodes as alternating current. To receive data, the voltage measured at the elec-
trodes is ampliﬁed, ﬁltered, and rectiﬁed by an AC/DC converter and digitized by the
microcontroller’s analog-to-digital converter.
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818Langendorff setup) were performed with different
electrode and device distances (de ¼ 7.5 to 15 mm;
dd ¼ 40 to 70 mm; and dp ¼ 3 to 5 mm). During all
communication experiments (w7 h in total), no
interference with cardiac function was observed (i.e.,
no arrhythmias were induced). Figure 5A illustrates
the 7 transfer functions between the RA and the RV.
The signal attenuation is higher for lower frequencies
(1 to 10 kHz). In the frequency range between 100 kHz
and 1 MHz, a better signal transmission is obtained,
and the attenuation remains approximately constant.
Due to contraction of the heart and the resulting
deformation of the myocardium, the attenuation
varies during the heart cycle. This variation
remained <5 dB.FIGURE 4 In Vivo Experiment Setup
Top view of the heart of the in vivo dual-chamber pacing
experiment. The positions of the electrode ﬁxation plates are
indicated by the triangles: right atrium (RA), right ventricle (RV),
and left ventricle (LV).Figure 5B shows the transfer function in blood with
various hematocrit levels at 2 different device dis-
tances (25 and 50 mm). Again, a better signal trans-
mission is obtained for higher frequencies, whereas
hematocrit does not affect the attenuation. However,
the attenuation is increased upon a larger device
distance. The inﬂuence of the other parameters was
separately assessed in the myocardial tissue samples.
Increasing the electrode distance de from 5 to 10 mm
resulted in a mean attenuation reduction of 11 dB (at
dp¼ 5 mm), and increasing the penetration depth dp
(thus increasing the electrode contact area) from 3 to
5 mm reduced the attenuation by 3 dB (at de¼ 10 mm).
This corresponds to a signal transmission improve-
ment of 250% and 40%, respectively.
The impedance Ze is decreasing with higher fre-
quencies. For the given dimensions, the measured
impedance of heart tissue is in the range of 400 to
1,000 U for frequencies between 100 kHz and 1 MHz.
The impedance is lower for smaller electrode distances
and for higher electrode penetration depths
(i.e., higher electrode contact surface area). Further-
more, it depends on the surrounding medium. The
impedance of blood is generally lower compared with
the myocardium, whereas the transfer function is
comparable.
PROTOTYPES. The PM prototypes (Figure 6A) can
communicate wirelessly via the heart by using intra-
body communication. The data are pulse position
modulated with an adjustable number of periods
(nperiods) per pulse at a communication frequency fc of
100 kHz up to 1 MHz and adjustable current ampli-
tude bI (Figure 6B). The prototypes exchange a syn-
chronization message at every heartbeat. The time
tsync required for sending one synchronization mes-
sage depends on communication-speciﬁc parameters
and can range from 0.3 ms (nperiods ¼ 1; fc ¼ 1 MHz) to
14 ms (nperiods ¼ 5; fc ¼ 100 kHz), for example. For 1
synchronization message, 17 pulses are required to
transmit 40 bits of data. The following information is
implemented in this data package: preamble, mes-
sage number, source (identiﬁcation of transmitting
PM), destination (identiﬁcation of receiving PM),
message type and length, pacing-related parameters
(heart rate, atrioventricular pacing delay, and pacing
activity), and cyclic redundancy check.
DUAL-CHAMBER PACING. The prototypes success-
fully performed leadless dual-chamber pacing in D00
mode during 3 in vivo trials. First, dual-chamber
pacing on the RA and RV was tested. The atrial PM
served as master device (atrial-based timing) and
dictated the actual pacing rate (120 to 150 beats/min),
the atrioventricular pacing delay, and pacing activity
FIGURE 5 Signal Attenuation in the Heart and in Blood
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(A) Measured transfer function between the right atrium and the right ventricle. The dimensions in parentheses indicate the electrode dis-
tance and the device distance, respectively (de/dd). (B) Transfer function of blood with different hematocrit (Hct) levels measured at 2 device
distances.
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819(pacing on/off) to the receiving ventricular PM wire-
lessly. The atrioventricular delay was intentionally
set below physiological levels to observe the ven-
tricular excitation provoked dominantly by the pac-
ing stimulus. Pacing was asynchronously started and
stopped multiple times, with total pacing durations of
w20 min (>2,400 paced heartbeats) per in vivo
experiment. Upon setup of communication, every
single synchronization message was successfully
received, and the communication did not cause any
rhythm disturbances. The ECG sequence in Figure 7
shows the onset of leadless dual-chamber pacing
recorded: the atrial and ventricular pacing spikes are
indicated by arrows.FIGURE 6 Prototype and Representation of the Synchronization Me
PCB
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(A) Pacemaker prototype with electrode- and battery connectors and u
modulated synchronization message. The data are modulated as several
favorable for signal transmission. fc ¼ communication frequency; PCB ¼The communication frequency fc was varied from
200 kHz to 1 MHz. Due to different attenuations in
the various experiments, the transmitter current
amplitude bI was adapted to obtain a reliable
communication (Table 1). This resulted in Esync of 0.3
to 1.5 mJ, which corresponds to an average power
Psync of 0.6 to 3 mW for 120 beats/min pacing fre-
quency. The duration tsync of sending 1 synchroniza-
tion message was 0.9 to 7.2 ms, depending on
communication settings.
Dual-chamber pacing was also successfully tested
in the LV and RV. Here, the left ventricular PM served
as master device and pacing was performed with
LV-RV pacing delays of 20 ms and 40 ms.ssage
or
B
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time
ser interface. (B) Schematic representation of the pulse position–
short pulses, which have a communication frequency fc that is
printed circuit board.
FIGURE 7 ECG Sequence of Leadless Dual-Chamber Pacing
Electrocardiogram (ECG) recorded during a dual-chamber test of the leadless pacemakers on the right atrium and right ventricle. The intrinsic
heart rate was 98 beats/min. Dual-chamber pacing (D00) was performed at 120 beats/min and with 50 ms atrioventricular delay. The atrial
(A) and ventricular (V) pacing spikes are indicated by the arrows.
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820DISCUSSION
In this proof-of-concept study, we show, to the best
of our knowledge, for the ﬁrst time the feasibility of
leadless cardiac dual-chamber pacing using intrabody
communication. Intrabody communication has
shown to be a suitable highly energy-efﬁcient wire-
less communication method. This technology offers
additional advantages such as the lack of an addi-
tional antenna (minimizing space requirements) and
a short communication connection time.TABLE 1 Communication Settings and Pacing Parameters During the
Electrode
Distance de
Device Distance
RA–RV dd (mm)
Pacing Threshold (V @ ms)
RA RV LV
15 mm 50 0.8 @ 1.5 1.0 @ 1.5 1.1 @ 1.5 1
10 mm 40 3.4 @ 0.5 1.7 @ 0.5 1.5 @ 0.5
15 mm 60 1.0 @ 1.0 1.5 @ 0.5 1.0 @ 0.5
LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle.ENERGY CONSUMPTION. The energy needed for
PM synchronization strongly depends on
communication-speciﬁc parameters. The transmitted
power for communication was already low (0.6 to 3
mW) during the in vivo experiments. However,
slightly changing some of the communication pa-
rameters can further decrease Psync: using npulses ¼ 1
and a communication frequency of 1 MHz would
result in 12 nW of Psync considering a heart rate of
60 beats/min (bI¼ 1 mA). This approach corresponds
to only w0.1% of the power consumption of a3 In Vivo Leadless Dual-Chamber Pacing Experiments
Pacing Impedance (U)
RA–RV
Delay (ms)
Communication
Frequency fc (kHz)
Current bI
(mA)RA RV LV
,046 1,244 1,153 50 200 1.0
775 898 771 50 200, 500, 1,000 3.3
726 1,234 975 50 500, 1,000 4.0
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821contemporary leadless PM. Furthermore, by
increasing the gain of the receiving ampliﬁer, the
transmitter current could be reduced.
Psync is the power applied to the tissue for
communication and does not include the power
consumption of the electronic circuits itself or the
pacing stimulus. The prototypes’ power consumption
is relatively high (in the milliwatt range) due to the
use of, for example, a microcontroller board, discrete
off-the-shelf components, and the integration of a
convenient user interface with visual feedback
directly on the PM modules. However, the elec-
tronics’ power consumption as well as the size could
be reduced dramatically by the implementation of an
integrated circuit, as done in commercial leadless
PMs. Another strategy to reduce power consumption
is the implementation of deﬁned time slots for
communication. Because receiving data requires
most of the power, the devices should switch to sleep
mode outside the communication time (e.g., during a
blanking period), in which the power consumption is
virtually zero.
COMMUNICATION. The transfer function measure-
ments showed that the signal attenuation is higher
for lower frequencies (1 to 10 kHz). This effect is
mainly caused by the polarization impedance at the
electrode–electrolyte interface, which is higher in this
frequency range (17). In the frequency range between
100 kHz and 1 MHz, a better signal transmission is
obtained, and the attenuation remains approximately
constant. Hence, a communication frequency equal to
or higher than w100 kHz is favorable for intracardiac
signal transmission.
The absolute signal attenuation varied between the
experiments involving beating hearts, which was
mainly caused by the different dimensions. In gen-
eral, the attenuation is higher for larger device dis-
tances. However, it can be reduced by a larger
electrode distance de and deeper penetration depth
dp. Increasing dp leads to a larger electrode contact
area, which is the actual reason for decreased signal
attenuation.
The dependence of the attenuation on the relative
spatial PM position also affects energy consumption.
In general, a higher signal attenuation requires
either a higher transmitter power or a more powerful
ampliﬁer on the receiving PM. In a real-world
setting, these parameters could be dynamically
adapted to optimize power consumption. Due to
contraction of the heart and movement of the PMs,
signal attenuation can even vary during a heartbeat.
In the performed experiments, this variation was
small (<5 dB), but it might be higher in differentscenarios. Therefore, it is important to provide
enough transmission budget to ensure a reliable
communication.
The acute safety of the communication method has
been shown by the lack of any unwanted arrhyth-
mias. Due to the small energy content of a synchro-
nization message (smaller than a typical pacing
impulse), other adverse events such as tissue heating
can also be excluded.
IMPLICATIONS AND CLINICAL CONSIDERATIONS. A
crucial aspect of the presented wireless communica-
tion method is its ability to be integrated into
contemporary leadless PMs. The dimensions and the
design of these devices mainly follow the re-
quirements of catheter-based implantation and the
space constraints in the heart. The electrode design is
optimized for cardiac pacing, but it would be desir-
able if the same electrodes could be simultaneously
used for communication. The basic measurements
have shown that higher electrode distances, as well as
larger electrode surface areas, lead to lower signal
attenuation. Fortunately, commercial leadless PMs
have similar or even higher electrode distances de
(Nanostim: >10 mm; Micra: 18 mm) and larger elec-
trode surface areas than those used in the presented
experiments. The communication of the Nanostim is
based on a similar idea as presented in the present
study (7,18). However, the transmission characteris-
tics to an external programmer differ signiﬁcantly,
and the restrictions on energy consumption are much
lower (only temporary, short interrogations are
performed, and the energy consumption of the pro-
grammer does not play a role). Moreover, our method
allows for communication independent from the
cardiac cycle.
Intrabody communication offers great advantages
in terms of safety and hacking protection because the
communication signal is conﬁned to the human body
(i.e., the body does not act as an antenna for the used
communication frequency). Direct physical contact of
a data transmitter with the body is required to
establish a connection to the PMs. Thus, malicious
change of the pacing parameters and leakage of sen-
sitive information (e.g., PM settings) to surroundings
is prevented. In addition, the use of low frequencies
prevents hacking from conventional wireless trans-
mitters (e.g., Bluetooth, ZigBee), which use a
different frequency band.
This study presents a leadless dual-chamber PM.
By implanting an additional leadless PM in the LV
that communicates with the other 2 devices, the
presented concept might also be extended to a lead-
less cardiac resynchronization therapy system.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Leadless PMs successfully overcome the lead-related
limitations of conventional PMs, but they are thus far
limited to single-chamber pacing. This study pre-
sented a proof of concept of a highly energy-efﬁcient
wireless communication method that may be used by
multiple implanted leadless PMs for synchronization
and may enable leadless dual-chamber pacing and
leadless cardiac resynchronization therapy. In vitro
and in vivo measurements provided a better under-
standing of the propagation of a communication
signal in the heart and enabled the development of
leadless dual-chamber PM prototypes that are opti-
mized for intrabody communication in the heart.
TRANSLATIONAL OUTLOOK: At this time, the
leadless dual-chamber PM prototypes have been
successfully tested in 3 animal models. Further mea-
surements will allow speciﬁcation of a wider signal
attenuation range and assessment of additional
inﬂuential parameters such as the relative spatial
position of the PMs. Future miniaturization of the
prototypes will allow for long-term endocardial
testing.
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822STUDY LIMITATIONS. To simplify the in vivo exper-
iments and to allow for better control of electrode
placement, the needle electrodes were placed in an
epicardial position. In real-life, leadless PMs are
implanted in an endocardial position, where the
cathode is in contact with myocardial tissue and the
anode surrounded mainly by blood. However, the
measurements in blood showed that blood has a
lower impedance but offers similar signal attenuation
as the myocardium. Therefore, it is reasonable to as-
sume that the presented results are applicable to
endocardial conditions as well.
Furthermore, the electrodes were arranged in a
near-parallel conﬁguration. However, different rela-
tive electrode angles may lead to different attenua-
tions. The dependence of signal attenuation on
geometric relations between the PMs is a general
limitation of intrabody communication. The attenu-
ation might be increased due to an altered device
orientation, for example. Consequently, the trans-
mitter current may need to be increased, which
would result in a higher power consumption.
CONCLUSIONS
Intrabody communication has shown to be a prom-
ising and energy-efﬁcient wireless communication
method for leadless dual-chamber PMs. The signal
attenuation depends on the relative spatial position
of the devices and can vary also during the heart cy-
cle. By using suitable communication settings, the
transmission power can be reduced drastically. In
general, higher communication frequencies lead to
better signal transmission as well as to a lower
transmitted energy. The electrode design also plays
an important role, whereby the electrodes of com-
mercial leadless PMs seem to be suitable for intrabody
communication.
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